← Back to Search

Core stabilization for Patellofemoral Maltracking

N/A
Waitlist Available
Led By Kenneth E Learman, PhD, PT
Research Sponsored by Youngstown State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

The investigators hypothesize that the use of trunk (core) stabilization exercises early in treatment combined with lower extremity exercises will enhance the outcome over lower extremity exercises alone in the treatment of young athletes with anterior knee pain.

Eligible Conditions
  • Patellofemoral Maltracking
  • Patellofemoral Pain Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lower extremity functional scale
Secondary study objectives
Kujala anterior knee pain scale
Numeric pain rating scale
Patient specific functional scale
Other study objectives
Global rating of change
Self-reported percent recovery

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Core stabilizationExperimental Treatment1 Intervention
This arm will receive 3 weeks of core stabilization training followed by 3 weeks of lower extremity stretching and strengthening as appropriate to address impairments noted in the examination and to progress function.
Group II: Lower extremity training onlyActive Control1 Intervention
This arm with receive 6 weeks of impairment based stretching and strengthening to restore function.

Find a Location

Who is running the clinical trial?

Youngstown State UniversityLead Sponsor
26 Previous Clinical Trials
1,934 Total Patients Enrolled
Kenneth E Learman, PhD, PTPrincipal InvestigatorYoungstown State University
~4 spots leftby Nov 2025